Vivos therapeutics receives first ever fda 510(k) clearance for oral device treatment of severe obstructive sleep apnea

With this unprecedented fda clearance, vivos redefines what it means to have a truly non-invasive treatment for all levels of osa severity, opening new revenue opportunities for vivos with this unprecedented fda clearance, vivos redefines what it means to have a truly non-invasive treatment for all levels of osa severity, opening new revenue opportunities for vivos
VVOS Ratings Summary
VVOS Quant Ranking